FT

FDA panel debates authorisation of Pfizer/BioNTech vaccine

US regulator poised to make final decision after it receives advisory committee’s recommendation

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button